COMMON STOCK PURCHASE WARRANT NRX PHARMACEUTICALS, INC.Common Stock Purchase Warrant • March 29th, 2024 • NRX Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledMarch 29th, 2024 Company IndustryTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Tony Baumer or his assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time during the six (6) month period following the Issue Date; provided, however, if the Common Stock trades at or above $1.20 per share (subject to adjustment for stock splits, stock dividends, stock combinations, recapitalizations or other similar events), as reported on Bloomberg, L.P. (or an equivalent, reliable reporting service mutually acceptable to and hereafter designated by Holder and the Company), the Holder may exercise this Warrant prior to the six (6) month anniversary of the Issue Date (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on February 28, 2029 (the “Termination Date”) but not thereafter, to subscribe for and purchase from NRX Pharmaceuticals, Inc., a Delaware corporation (the “Company”
COMMON STOCK PURCHASE WARRANT BIOLABMART INC.Common Stock Purchase Warrant • March 13th, 2017 • Biolabmart Inc.
Contract Type FiledMarch 13th, 2017 CompanyTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [ ] (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Issue Date (as defined above) and on or prior to the close of business on December 31, 2019 (the “Termination Date”) but not thereafter, to subscribe for and purchase from BioLabMart Inc., a Wyoming corporation (the “Company”), up to [ ] shares (the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
Careview Communications, Inc. 8-KCommon Stock Purchase Warrant • February 2nd, 2017 • CareView Communications Inc • Radio & tv broadcasting & communications equipment
Contract Type FiledFebruary 2nd, 2017 Company IndustryTHIS COMMON STOCK PURCHASE WARRANT ('WARRANT") SUPERSEDES ALL OTHER WARRANTS ISSUED TO ROCKWELL HOLDINGS I, LLC BY CAREVIEW COMMUNICATIONS, INC. (THE "COMPANY"). THIS WARRANT IS BEING REISSUED SOLELY FOR THE PURCHASE OF EXTENDING THE TERMINATION DATE OF THE WARRANT BY FIVE YEARS PURSUANT TO THE EXECUTION OF THE SETTLEMENT AND LLC INTEREST PURCHASE AGREEMENT ENTERED INTO ON JANUARY 31, 2017 WITH AN EFFECTIVE DATE OF JANUARY 1, 2017.
COMMON STOCK PURCHASE WARRANT BOSTON THERAPEUTICS, INC.Common Stock Purchase Warrant • October 5th, 2012 • Boston Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledOctober 5th, 2012 Company IndustryTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _______________or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Issue Date set forth above (the “Initial Exercise Date”) and on or prior to the earlier to occur of (i) the close of business on the fifth anniversary of the Initial Exercise Date and or (ii) the date fixed for redemption of this Warrant as provided in Section 5 of this Warrant (the “Termination Date”) but not thereafter, to subscribe for and purchase from Boston Therapeutics, Inc., a Delaware corporation (the “Company”), up to the number of shares of the Company’s common stock, $0.001 par value (“Common Stock”) equal to the warrant shares set forth above (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price,
COMMON STOCK PURCHASE WARRANT IMPRIMIS PHARMACEUTICALS, INC. Warrant Shares: _______ Initial Exercise Date: April 30, 2012Common Stock Purchase Warrant • April 27th, 2012 • Imprimis Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledApril 27th, 2012 Company IndustryTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the three year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Imprimis Pharmaceuticals Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
COMMON STOCK PURCHASE WARRANT To Purchase __________ Shares of Common Stock of Mechanical Technology IncorporatedCommon Stock Purchase Warrant • December 15th, 2006 • Mechanical Technology Inc • Measuring & controlling devices, nec
Contract Type FiledDecember 15th, 2006 Company IndustryTHIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, _____________ (the "Holder"), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after June __, 2007 (the "Initial Exercise Date") and on or prior to the close of business on December __, 2011 (the "Termination Date") but not thereafter, to subscribe for and purchase from Mechanical Technology Incorporated, a New York corporation (the "Company"), up to ______ shares (the "Warrant Shares") of Common Stock, par value $0.01 per share, of the Company (the "Common Stock"). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).